Robert Mo

Robert Mo is a seasoned professional in drug product development and CMC (Chemistry, Manufacturing, and Controls) with extensive experience across multiple prestigious organizations. Currently serving as Senior Director of CMC Drug Product Development at Enanta Pharmaceuticals since March 2025, Robert previously held senior director roles at Formation Bio and PharmaBlock Group, where responsibilities included leading drug product programs and enhancing business practices. At Akebia Therapeutics, Robert directed drug product development and was integral in the successful registration of the drug Vafseo® (vadadustat). Earlier experience at Pfizer involved serving as a Senior Scientist focused on formulation for research and clinical programs, while initial roles included product formulation development at Allergan and academic research at the University of Southern California, culminating in a Ph.D. in Pharmaceutical Sciences. Robert also holds a BS in Biomedical Engineering from Columbia Engineering and has pursued finance studies at Harvard Extension School.